Navin P. Wadehra, MD

Northwest Georgia Oncology Centers, P.C. Douglasville Cancer Center 6002 Professional Pkwy
Suite 220
Douglasville, GA 30134
Phone: (678) 715-9690
Fax: (678) 581-7140

Navin P. Wadehra, MD joined the cancer care team of Northwest Georgia Oncology Centers, P.C. (NGOC) in 2006 after completing his Fellowship in Medical Oncology and Hematology at Ohio State University in Columbus, OH.

With a special interest in breast, lung, gastrointestinal and head and neck cancers, Dr. Wadehra is actively involved in cancer research and clinical trials to find a cancer cure and provide his patients with the most advanced cancer treatment available in Georgia.

“Most cancers are complex and no two patients will have the same needs. I try to work with each patient to create a custom treatment plan for the best possible outcome.”

Dr. Wadehra delivers patient-centered cancer care at NGOC’s Douglasville Cancer Center.

Personal DataBirthplace: Kansas City, Missouri
Undergraduate EducationBS, Biology, May 1994
University of Illinois
Champaign, IL
Medical EducationDoctor of Medicine
University of Illinois, College of Medicine
Champaign, IL
May 1999
Postdoctoral TrainingRESIDENCY
Internal Medicine
University of Illinois
Chicago, IL
July 1999 – June 2003

Hematology & Medical Oncology
Ohio State University
Columbus, OH
July 2003 – June 2006
Board CertificationAmerican Board of Internal Medicine, Internal Medicine, 2005
American Board of Internal Medicine, Medical Oncology, 2006
American Board of Internal Medicine, Hematology, Board Eligible
Medical LicensureState of Georgia, 2006 (Active)
Professional SocietiesAmerican College of Physicians
American Society of Clinical Oncology
American Society of Hematology
Cobb County Medical Society
Georgia Society of Clinical Oncology
Medical Association of Georgia
Southern Medical Association
HonorsPhi Eta Sigma Honor Society, 1991
Graduated with Distinction, Honors Biology Program, 1994
NIH T32 CA 09338-20 Research Grant: Combination Treatment of
Mantle Cell Lymphoma with PS-341 and Rituximab, 2004
Recipient, ASH Travel Award, 2005
Major Research InterestsClinical Trials (Oncology & Hematology)